ARTICLES BY THIS AUTHOR
- 1/5/2024
Web app for biosimilars education debuts
The app provides resources for engaging patients when switching to a biosimilar and understanding managed care requirements. - 1/5/2024
Dollar General celebrates Aurora distribution center progress, grand opening of newly remodeled DG Market in Texas
The Aurora facility is expected to create approximately 400 new jobs, while the upgraded DG Market in Lockney, Texas, offers an expanded selection of fresh meat, dairy, produce and more. - 1/5/2024
CVS Pharmacy revamps loyalty program
CVS Pharmacy's loyalty program now includes two membership tiers: ExtraCare and ExtraCare Plus. - 1/5/2024
BJ’s Wholesale Club to open in North Jacksonville, Fla.
The North Jacksonville location marks BJ’s 242nd club and 37th club in Florida. - 1/5/2024
CVS Health makes executive appointments
Tom Cowhey has been named chief financial officer, and Mike Pykosz has been appointed president of health care delivery. - 1/4/2024
WBA posts Q1 results
WBA’s first quarter sales increased 10% from the year-ago quarter to $36.7 billion, an increase of 8.7% on a constant currency basis. - 1/4/2024
Giant’s Feeding School Kids initiative returns
The expanded program invites customers to support public school districts’ food programs through March 31. - 1/4/2024
Lupin receives FDA nod for 3 generics
The FDA has approved Lupin's generic Alrex, generic Zyloprim and generic Januvia. - 1/3/2024
CVS Caremark accelerates biosimilars adoption through formulary changes
CVS Caremark announced that effective April 1, 2024, Humira will be removed from its major national commercial template formularies and Humira biosimilars will be covered. - 1/3/2024
Natco Pharma completes transition of DASH Pharmaceuticals into Natco Pharma USA
As of Jan. 2, all products marketed by the company will transition to the Natco Pharma USA label, with no changes to the current NDC numbers.